New Results
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
doi: https://doi.org/10.1101/2021.04.23.441075
Satoshi Imanishi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Lijuan Huang
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Shoko Itakura
2Graduate School of Biological Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Masamichi Ishizaka
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Tsukamoto
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Saito
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Yoichi Iwasaki
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Tomohiro Yamaguchi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Etsuko Miyamoto-Sato
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Article usage
Posted April 23, 2021.
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
Subject Area
Subject Areas
- Biochemistry (13369)
- Bioengineering (10176)
- Bioinformatics (32551)
- Biophysics (16750)
- Cancer Biology (13839)
- Cell Biology (19663)
- Clinical Trials (138)
- Developmental Biology (10625)
- Ecology (15726)
- Epidemiology (2067)
- Evolutionary Biology (20031)
- Genetics (13230)
- Genomics (18356)
- Immunology (13464)
- Microbiology (31515)
- Molecular Biology (13132)
- Neuroscience (68666)
- Paleontology (509)
- Pathology (2128)
- Pharmacology and Toxicology (3672)
- Physiology (5730)
- Plant Biology (11784)
- Synthetic Biology (3307)
- Systems Biology (8034)
- Zoology (1813)